Acute Stroke Management: A Comprehensive Emergency Guideline

Evidence-based guideline for recognition, evaluation, thrombolysis, thrombectomy, and management of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage in the emergency department.

Records
5
Last revised
March 2026
Editorial responsibility
The Clinical Database

A comprehensive, evidence-based clinical guideline for the emergency department recognition, evaluation, and management of acute stroke — including ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage. This resource synthesizes recommendations from the major international stroke and cardiovascular professional societies, emergency medicine expert panels, neurointerventional working groups, and European stroke organizations into a single integrated reference for emergency physicians, neurologists, neurointerventionalists, intensivists, and advanced practice providers who manage patients presenting with acute cerebrovascular emergencies.1 2 3 4 5 6 7

Stroke is the fifth leading cause of death and a leading cause of serious long-term disability in the United States, with approximately 795,000 people experiencing a new or recurrent stroke each year. Globally, stroke is the second leading cause of death and third leading cause of disability. The foundational principle of acute stroke management — “time is brain” — reflects the estimated loss of 1.9 million neurons per minute during a large vessel occlusion. The paradigm has shifted from a purely time-based approach to one that integrates tissue-based imaging (perfusion mismatch) to identify patients who may benefit from reperfusion therapy even in extended time windows. The cornerstones of acute stroke care — rapid recognition, emergent neuroimaging, intravenous thrombolysis, endovascular thrombectomy, blood pressure management, and neuroprotective strategies — are supported by robust randomized controlled trial evidence and form the basis of modern stroke systems of care.


Contents:

PartTitleCoverage
Part 1Prehospital Recognition, ED Evaluation & NeuroimagingStroke types and pathophysiology; prehospital stroke scales (CPSS, LAMS, RACE, FAST-ED, VAN); ED evaluation; complete NIHSS scoring table (all 15 items); focused history; laboratory evaluation; neuroimaging (NCCT, CTA, CTP, MRI/DWI); ASPECTS scoring with complete regional anatomy
Part 2Intravenous ThrombolysisAlteplase dosing and administration; 0-3 hour and 3-4.5 hour inclusion/exclusion criteria (complete tables); tenecteplase emerging evidence (AcT, TASTE, ATTEST-2); blood pressure management before and after thrombolysis; orolingual angioedema recognition and management; hemorrhagic transformation
Part 3Endovascular Thrombectomy & Blood Pressure ManagementEVT indications and patient selection; landmark trials (MR CLEAN, ESCAPE, EXTEND-IA, SWIFT PRIME, REVASCAT); extended window therapy (DAWN, DEFUSE-3); door-to-groin targets; anesthesia considerations (GA vs conscious sedation); comprehensive BP management across all stroke types; antihypertensive agent dosing tables
Part 4Intracerebral HemorrhageICH pathophysiology and etiology; ICH Score (complete table); hematoma expansion prediction; acute blood pressure management (INTERACT2, ATACH-2); anticoagulant reversal (warfarin, DOACs, heparin — complete protocols); surgical intervention criteria (STICH, STICH II, MISTIE III, ENRICH); ICP management; prognostication
Part 5Subarachnoid Hemorrhage, TIA & Special PopulationsSAH presentation and diagnosis; Hunt & Hess scale; WFNS grade; Fisher/modified Fisher CT grading; aneurysm securing (coiling vs clipping); vasospasm prevention (nimodipine); delayed cerebral ischemia; TIA evaluation (ABCD2 score, dual antiplatelet — CHANCE, POINT); stroke mimics; posterior circulation stroke; wake-up stroke; stroke in pregnancy; pediatric stroke


  1. Powers WJ, Rabinstein AA, Ackerson T, et al. “Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines.” Stroke. 2019;50(12):e344-e418. DOI: 10.1161/STR.0000000000000211 ↩︎

  2. Greenberg SM, Ziai WC, Cordonnier C, et al. “2022 Guideline for Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.” Stroke. 2022;53(7):e282-e361. DOI: 10.1161/STR.0000000000000407 ↩︎

  3. Hoh BL, Ko NU, Amin-Hanjani S, et al. “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.” Stroke. 2023;54(7):e314-e370. DOI: 10.1161/STR.0000000000000436 ↩︎

  4. Berge E, Whiteley W, Audebert H, et al. “European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.” Eur Stroke J. 2021;6(1):I-LXII. DOI: 10.1177/2396987321989865 ↩︎

  5. Edlow JA, Rabinstein AA, Traub SJ, Wijdicks EFM. “Diagnosis of reversible causes of coma.” Lancet. 2014;384(9959):2064-2076. DOI: 10.1016/S0140-6736(13)62184-4 ↩︎

  6. Wolf ME, Grotta JC, et al. “ACEP Clinical Policy: Use of Intravenous tPA for the Management of Acute Ischemic Stroke in the Emergency Department.” Ann Emerg Med. 2013;61(2):225-243. DOI: 10.1016/j.annemergmed.2012.11.005 ↩︎

  7. Turc G, Bhogal P, Fischer U, et al. “European Stroke Organisation (ESO) — European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic Stroke.” Eur Stroke J. 2019;4(1):6-12. DOI: 10.1177/2396987319832140 ↩︎

Frequently asked questions

What is the time window for thrombolysis in acute ischemic stroke?
IV alteplase given within 3 hours of symptom onset improves 90-day functional outcomes per the NINDS trial, and ECASS-III extended the window to 4.5 hours with modified eligibility criteria. Dosing is 0.9 mg/kg (maximum 90 mg), with 10% as a bolus and the remainder infused over 60 minutes. The number needed to treat for functional independence is approximately 7-10 within 3 hours and 14 in the 3-4.5 hour window.
Who is eligible for mechanical thrombectomy?
Standard eligibility is a confirmed large vessel occlusion on CTA or MRA (intracranial ICA, M1, or selected proximal M2), treatment within 6 hours of last known well, NIHSS of 6 or higher, and ASPECTS of 6 or higher. The DAWN and DEFUSE-3 trials extended treatment to 24 hours in patients selected by clinical-imaging or perfusion mismatch on advanced imaging, so time alone does not exclude a patient from treatment.
What are the main types of stroke?
Ischemic stroke accounts for about 87% of all strokes, intracerebral hemorrhage about 10%, and subarachnoid hemorrhage about 3%. Intracerebral hemorrhage carries a 30-day mortality of 30-50%, and subarachnoid hemorrhage most commonly results from a ruptured saccular aneurysm. Transient ischemic attack — transient neurological dysfunction without infarction on imaging — carries a 10-15% risk of stroke within 90 days, highest in the first 48 hours.

Acute Stroke Management — Part 5: Subarachnoid Hemorrhage, TIA & Special Populations

SAH presentation, Hunt & Hess scale, WFNS grade, Fisher CT grading, aneurysm management, vasospasm prevention, DCI, TIA evaluation (ABCD2, dual antiplatelet), stroke mimics, posterior circulation, wake-up stroke, pregnancy, and pediatric stroke.

Acute Stroke Management — Part 4: Intracerebral Hemorrhage

ICH pathophysiology, ICH Score, hematoma expansion, blood pressure management (INTERACT2, ATACH-2), anticoagulant reversal protocols, surgical intervention criteria (STICH, MISTIE III, ENRICH), and ICP management.

Acute Stroke Management — Part 3: Endovascular Thrombectomy & Blood Pressure Management

EVT indications, landmark trials, extended window therapy (DAWN, DEFUSE-3), anesthesia considerations, and comprehensive blood pressure management with antihypertensive dosing tables.

Acute Stroke Management — Part 2: Intravenous Thrombolysis

Alteplase and tenecteplase dosing, complete inclusion/exclusion criteria for 0-3h and 3-4.5h windows, blood pressure management peri-thrombolysis, orolingual angioedema, and hemorrhagic transformation.

Acute Stroke Management — Part 1: Prehospital Recognition, ED Evaluation & Neuroimaging

Stroke types, prehospital stroke scales (CPSS, LAMS, RACE, FAST-ED), complete NIHSS scoring, focused history, laboratory evaluation, and neuroimaging (NCCT, CTA, CTP, MRI/DWI, ASPECTS).